Baker Hughes (NYSE: BKR) CEO exercises options and sells 272,594 shares under 10b5-1 plan
Rhea-AI Filing Summary
Baker Hughes Chairman, President and CEO Lorenzo Simonelli reported an exercise-and-sale transaction in Baker Hughes Co stock. He exercised stock options for 187,344 shares of Class A Common Stock at an exercise price of $35.70 per share, then sold 272,594 shares at a weighted average price of $58.79 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 10, 2025. After these transactions, Simonelli directly holds 866,444 shares of Baker Hughes Class A Common Stock.
Positive
- None.
Negative
- None.
Insights
Pre-planned CEO option exercise and partial share sale looks routine.
Lorenzo Simonelli exercised stock options for 187,344 Baker Hughes shares at an exercise price of $35.70, converting derivative compensation into common stock. He then sold 272,594 shares at a weighted average price of $58.79 per share.
The filing notes the sale was made under a Rule 10b5-1 trading plan adopted on November 10, 2025. Such plans are pre-arranged, which typically makes the timing of the sale less informative about the executive’s short-term view of the stock.
Following the transactions, Simonelli directly holds 866,444 shares of Class A Common Stock. The derivativeSummary is empty, indicating this particular option grant, issued on August 1, 2017 and vesting over three years, has been fully exercised. Future filings may show whether additional grants are exercised or sold over time.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 187,344 | $0.00 | -- |
| Exercise | Class A Common Stock | 187,344 | $35.70 | $6.69M |
| Sale | Class A Common Stock | 272,594 | $58.79 | $16.03M |
Footnotes (1)
- This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.95 to $59.40, inclusive. Details on the number of shares sold at each separate price will be provided to the Issuer, any shareholder of the Issuer, or staff of the Securities and Exchange Commission upon request. The stock option was granted on August 1, 2017 and vested in three equal annual installments beginning one year from the date of grant.